These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Targeting sialic acid residues on lung cancer cells by inhalable boronic acid-decorated albumin nanocomposites for combined chemo/herbal therapy. Elgohary MM; Helmy MW; Abdelfattah EA; Ragab DM; Mortada SM; Fang JY; Elzoghby AO J Control Release; 2018 Sep; 285():230-243. PubMed ID: 30009892 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy. Ali OM; Bekhit AA; Khattab SN; Helmy MW; Abdel-Ghany YS; Teleb M; Elzoghby AO Colloids Surf B Biointerfaces; 2020 Apr; 188():110824. PubMed ID: 32023511 [TBL] [Abstract][Full Text] [Related]
6. Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma. Kabary DM; Helmy MW; Elkhodairy KA; Fang JY; Elzoghby AO Colloids Surf B Biointerfaces; 2018 Sep; 169():183-194. PubMed ID: 29775813 [TBL] [Abstract][Full Text] [Related]
7. Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model. Roa WH; Azarmi S; Al-Hallak MH; Finlay WH; Magliocco AM; Löbenberg R J Control Release; 2011 Feb; 150(1):49-55. PubMed ID: 21059378 [TBL] [Abstract][Full Text] [Related]
8. Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer. Tomoda K; Ohkoshi T; Hirota K; Sonavane GS; Nakajima T; Terada H; Komuro M; Kitazato K; Makino K Colloids Surf B Biointerfaces; 2009 Jul; 71(2):177-82. PubMed ID: 19264458 [TBL] [Abstract][Full Text] [Related]
9. Inhalable Dual-Targeted Hybrid Lipid Nanocore-Protein Shell Composites for Combined Delivery of Genistein and All-Trans Retinoic Acid to Lung Cancer Cells. Kamel NM; Helmy MW; Abdelfattah EZ; Khattab SN; Ragab D; Samaha MW; Fang JY; Elzoghby AO ACS Biomater Sci Eng; 2020 Jan; 6(1):71-87. PubMed ID: 33463208 [TBL] [Abstract][Full Text] [Related]
10. Distribution of effervescent inhalable nanoparticles after pulmonary delivery: an in vivo study. Al-Hallak MH; Sarfraz MK; Azarmi S; Roa WH; Finlay WH; Rouleau C; Löbenberg R Ther Deliv; 2012 Jun; 3(6):725-34. PubMed ID: 22838068 [TBL] [Abstract][Full Text] [Related]
11. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery. Huang H; Yang DP; Liu M; Wang X; Zhang Z; Zhou G; Liu W; Cao Y; Zhang WJ; Wang X Int J Nanomedicine; 2017; 12():2829-2843. PubMed ID: 28435261 [TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species responsive drug releasing nanoparticle based on chondroitin sulfate-anthocyanin nanocomplex for efficient tumor therapy. Jeong D; Bae BC; Park SJ; Na K J Control Release; 2016 Jan; 222():78-85. PubMed ID: 26686664 [TBL] [Abstract][Full Text] [Related]
13. Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer. Choi SH; Byeon HJ; Choi JS; Thao L; Kim I; Lee ES; Shin BS; Lee KC; Youn YS J Control Release; 2015 Jan; 197():199-207. PubMed ID: 25445703 [TBL] [Abstract][Full Text] [Related]
14. Chondroitin sulfate modified and adriamycin preloaded hybrid nanoparticles for tumor-targeted chemotherapy of lung cancer. Liang X; Liang X Kaohsiung J Med Sci; 2021 May; 37(5):411-418. PubMed ID: 33340254 [TBL] [Abstract][Full Text] [Related]
15. Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer. Lv S; Tang Z; Li M; Lin J; Song W; Liu H; Huang Y; Zhang Y; Chen X Biomaterials; 2014 Jul; 35(23):6118-29. PubMed ID: 24794923 [TBL] [Abstract][Full Text] [Related]
16. Inhalable bioresponsive chitosan microspheres of doxorubicin and soluble curcumin augmented drug delivery in lung cancer cells. Jyoti K; Pandey RS; Kush P; Kaushik D; Jain UK; Madan J Int J Biol Macromol; 2017 May; 98():50-58. PubMed ID: 28130133 [TBL] [Abstract][Full Text] [Related]
17. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics. Shen X; Li T; Chen Z; Geng Y; Xie X; Li S; Yang H; Wu C; Liu Y Int J Nanomedicine; 2017; 12():4299-4322. PubMed ID: 28652734 [TBL] [Abstract][Full Text] [Related]
18. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery. Lee JY; Chung SJ; Cho HJ; Kim DD Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228 [TBL] [Abstract][Full Text] [Related]
19. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy. He Y; Su Z; Xue L; Xu H; Zhang C J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977 [TBL] [Abstract][Full Text] [Related]
20. Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy. Han Y; Zhang P; Chen Y; Sun J; Kong F Int J Mol Med; 2014 Jul; 34(1):191-6. PubMed ID: 24804644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]